ACADIA Pharmaceuticals, Inc. (ACAD)
21.38
-0.18
(-0.83%)
USD |
NASDAQ |
Jun 08, 14:28
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 0.0211 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Biogen, Inc. | 2.153 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.637M |
| Revenue (Quarterly) | 268.06M |
| Total Expenses (Quarterly) | 264.42M |
| Enterprise Value | 2.888B |
| Gross Profit Margin (Quarterly) | 90.75% |
| Profit Margin (Quarterly) | 1.36% |
| Earnings Yield | 10.27% |
| Operating Earnings Yield | 2.21% |
| Normalized Earnings Yield | 10.27 |